Reportlinker finds all market research
reports published by official sources!
- Home
- Life Sciences
- Biotechnology
- Biopharmaceutical
- Germany
- Biosimilar Business in Germany and Japan
Biosimilar Business in Germany and Japan
- This 20-page industry report was published in May 2011.
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
Talk to Sam
+1 917 267 7886
Share
Biopharmaceutical Industry in Germany : Latest Downloads
Biosimilar in The United States : Innovation and Technology Trends (biosimilar, monoclonal antibody)
- Industry report
- November 2012
- 35 pages
... Sandoz analysis rising demand and high cost of biologics will continue to strain shrinking health care budgetsgg biologics contribute to increased costs worldwide biosimilars are expected to relieve ...
Biosimilar Sector (biosimilar, biologic medicine) in The United States
- Industry report
- July 2012
- 6 pages
... As an adjuvant in oncology in unsupported healthcare systems, but a biosimilar might. Even the use of a granulocyte colony-stimulating factor (g-csf), filgrastim, as an adjuvant in oncology to reduce ...
Biosimilar Sector (biosimilar, biologic medicine) in The United States
- Industry report
- July 2012
- 8 pages
World Biopharmaceutical Industry Brief
12 months agoBiosimilar Sector Brief
9 months agoBiopharmaceutical Sector Brief
11 months agoBiopharmaceutical Industry Overview
12 months agoEnzyme Sector Analysis
3 months agoBiopharmaceutical Industry Brief
8 months agoBiopharmaceutical Sector Brief
8 months agoMore Reports:
Biopharmaceutical in Australia (8)
Company Reports
Country Reports
Germany
World
Japan
Biopharmaceutical Industry in Germany : Latest Reports
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion
- $ 3 500
- Industry report
- January 2013
- by GBI Research
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion Summary GBI Research, the leading business ...
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
- $ 2 064
- Industry report
- May 2013
- by La Merie Publishing
Product Description The new Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development ...
Competitor Analysis: Erythropoiesis Stimulating Agents (ESA)
- $ 645
- Industry report
- April 2013
- by La Merie Publishing
Product description The Competitive Intelligence Report Erythropoiesis Stimulating Agents (ESA) as of April 2013 provides information on existing first and second generation epoetin products in regulated ...
More Reports:
Biopharmaceutical in China (12)
Reportlinker.com © Copyright 2013. All rights reserved.
